http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101407980-B1
Outgoing Links
Predicate | Object |
---|---|
classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12R2001-225 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12R2001-25 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L33-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L2-382 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-74 |
filingDate | 2011-12-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2014-06-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2014-06-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | KR-101407980-B1 |
titleOfInvention | Products containing Lactobacillus curvatus HY7601 and Lactobacillus plantarum KY1032 having improving hyperinsulinemia, hyperglycemia and hypertriglyceridemia as effective component |
abstract | The present invention relates to a product containing, as an active ingredient, Lactobacillus cabutus HY7601 and Lactobacillus plantarum KY1032 having an effect of improving liver function and improving hyperinsulinemia, hyperglycemia and hypertriglyceridemia, It is possible to reduce the liver weight gain, improve the fatty liver symptoms of fat accumulation in the liver, lower the triglyceride and cholesterol content in the liver, and regulate genes FAS, ME, ACC1, and genes related to fatty acid synthesis, HMGCR, ACAT1 , Reduces the expression of ACAT2, decreases hepatic AST and ALT levels, and reduces levels of insulin, ritestine, glucose, C-peptide, and triglycerides in the blood to improve liver function and hyperinsulinemia, hyperglycemia and hypertriglyceridemia having the effect of improving Lactobacillus Cinque's Better (Lactobacillus curvatus) HY7601 and Lactobacillus Planta Room (Lactob acillus plantarum ) KY1032, and functional foods and pharmaceutical compositions that affect hyperinsulinemia, hyperglycemia and hypertriglyceridemia. |
isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20220031311-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11104878-B2 |
priorityDate | 2011-12-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 574.